CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 8-K Event Regulation FD disclosure
- 4 Grant or award Director acquired 635 shares (grant or award)
- 4 Grant or award Director acquired 2,259 shares (grant or award)
- 4 Grant or award Director acquired 635 shares (grant or award)
- 4 Grant or award Director acquired 1,271 shares (grant or award)
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale President & CEO sold 100,000 shares at $10.38 ($1,038,000)
- 4 Option exercise Director acquired 15,000 shares (option exercise)
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Grant or award Chief Legal Officer acquired 34,000 shares (grant or award)
- 4 Grant or award Chief R&D Officer acquired 81,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 127,500 shares (grant or award)
- 4 Grant or award Exec. Director, Finance - PAO acquired 5,900 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 34,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 34,000 shares (grant or award)
Page 15 of 99 · 1,967 filings